7- clinical trials overview Flashcards

1
Q

what things are looked for in drug testing in humans?

A
  • Safety
  • Efficacy
  • Dose range finding (based on animal numbers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what must the drug be made in accordance to?

A

Good Manufacturing Practice (GMP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how much of the cost of the new drug is taken up in clinical trials?

A

60 to 70 % of the cost of new drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how many phases of trial?

A

3 main phases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are double blind studies?

A
  • Compare two groups of patients → one gets the drug, other gets the placebo
  • Patient does not know which group they are in
  • Doctor does not know which patients are getting placebos
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the true effect of the treatment?

A

subtracting the effects of the placebo group from the effects of the treatment group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the nuremberg code placed for? what are some characteristics of it?

A
  • placed for ethical reasons
  • Participation is voluntary
  • Informed consent
  • Prior animal studies
  • Benefits outweigh risks
  • Qualified scientists
  • No suffering
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when was the nuremberg code instituted and why?

A
  • created to prevent the atrocities carried out by the Nazis

- sought to improve the quality of experimental results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how many people are tested during phase one? and how long does it require?

A
  • small number of healthy volunteers (<100)

- requires less than 1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the purpose of phase one?

A

Safety only (try to find maximum safe dose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how much of the IND’s fail during phase one?

A

30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how many people are tested during phase two? and how long does it require?

A
  • small number of patients (200-300)

- requires less than 1 year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the purpose of phase two?

A
  • safety and efficacy

- establish effective dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how much of the IND’s fail during phase two?

A

70%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how many people are tested during phase three? and how long does it require?:

A
  • thousands of patients

- 1-4 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the purpose of phase three?

A

safety, efficacy, looking for rare side effects

17
Q

how much of the IND’s fail during phase three?

A

70%

18
Q

how long does it take for FDA to review the NDA

A

6 months to 1.5 years

19
Q

what happens during the market? list two things

A
  • Continue safety testing (phase 4)

- Find new indications

20
Q

what are orphan drugs? list some characteristics

A
  • Pharmaceutical agent for rare condition (fewer than 200,000 US patients)
  • Smaller clinical trials (fewer patients available)
  • 7 Year market exclusivity
  • Tax credits up to 50% of research costs
21
Q

what are modern safety standards? 4 things

A
  • Safety testing done in at least 2 species
  • At least one must be a primate
  • Must show that the drug is bioavailable
  • Must use relevant doses
22
Q

what are some upsides to the industry needing regulation? list 3

A
  • Ensures safe products
  • Ensures products work
  • Provides consumer protection
23
Q

what are some downsides to the industry needing regulation?

A
  • Controls access
  • Increases costs
  • Increases taxes
  • Limits access